Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Genmab A (GNMSF) Revenue (2024 - 2025)

Historic Revenue for Genmab A (GNMSF) over the last 2 years, with Q4 2025 value amounting to $1.1 billion.

  • Genmab A's Revenue rose 1462.62% to $1.1 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $3.7 billion, marking a year-over-year increase of 1919.26%. This contributed to the annual value of $3.7 billion for FY2025, which is 1919.26% up from last year.
  • Latest data reveals that Genmab A reported Revenue of $1.1 billion as of Q4 2025, which was up 1462.62% from $1.0 billion recorded in Q3 2025.
  • In the past 5 years, Genmab A's Revenue registered a high of $1.1 billion during Q4 2025, and its lowest value of $603.0 million during Q1 2024.